Skip to main content
. 2011 May 30;11:212. doi: 10.1186/1471-2407-11-212

Figure 4.

Figure 4

Inhibition of tumour angiogenesis by peptide P111-136. For immunohistochemical analysis, tumour sections were prepared and stained with anti-CD31 antibodies. (A), untreated tumours and (B), tumours treated with P111-136. Scale bar, 100 μm. (C), angiogenesis was quantified by image analysis of CD31-labelled endothelial cells. The data are mean areas +/- SD obtained from 5 control mice and 5 mice treated with P111-136. **p < 0.01 versus control.